chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ADMINISTERED VACCINE VIAL THAT OPENED MORE THAN 6 HOURS; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 29-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUL-2021, the subject experienced incorrect product storage. On 29-JUL-2021, the subject experienced administered vaccine vial that opened more than 6 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administered vaccine vial that opened more than 6 hours and incorrect product storage was not reported. This report was non-serious.
Pt c/o tachycardia and maybe anxiety.  Pt is an MD.  Tachycardia at 15 mins post vaccine- radial pulse 132 and BP 150/90.  Denied other symptoms.  Rechecked in 15 mins and HR 84-91 and BP 154/95.  Continued to deny any other symptoms to include CP or  SOB.  No change in mental status.  Declined  treatment in ED.  Kept and monitored for 15 more mins. and left 45 mins post vaccine.  Continued to state maybe he was anxious
Suspected myopericarditis.  55 yrs old female with history of tobacco use disorder, obesity, who presented with acute-onset chest discomfort radiating to her bilateral jaw and upper back. EMS noted STE on ECG. STEMI alerted was activated.  Patient was taken for emergent cardiac catheterization, which disclosed essentially normal coronary vessels. It was felt unlikely she had coronary vasospasm per interventional cardiology. Troponin continued to rise, to peak 10.8 prior to discharge.  She underwent the above-noted CTA to rule out aortopathy, which was reassuring. TTE with normal LV size and function, hyperdynamic systolic function, no wall motion abnormalities, normal RV size and function, and with trivial pericardial effusion and no valvular disease.  She was initially started on dual antiplatelet therapy post catheterization as well as UFH drip, though this was subsequently discontinued given increased clinical suspicion for myocarditis.  She was started on colchicine and NSAIDs, with marked improvement to her chest discomfort. Given this, cardiology felt cMR not clearly indicated to assist with diagnosis. Per cardiology, plan to continue colchicine for 3 month course, plan to use only PRN NSAIDs rather than scheduled dosing.
During the first night (Friday) of the day of  the second injection of the Moderna Covid-19 vaccine, I developed chills and a slight fever for most of the night.  After the chills subsided during the second day, (Saturday) I developed a headache and tiredness that lasted through most of the second day, and through the night.  By the morning of  third day (Sunday), the tiredness was mostly gone, and I had only a slight headache that lingered but went way on the third day.
"I think I'm having an allergic reation"  Pt c/o tongue going numb last night but states he's getting feeling back into it now. States right side of face is swollen and drooping, and bil eye watering and itching.  Pt states no new foods, meds or substances withing the past 24 hours
pt recv vax 16MAY95; devel generalized sz 17MAY x 2; adm to hosp w/fever & lethargy; EEG nl; did well till 22MAY95 devel fever & another sz; seen in ER w/otitis;
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09May2022 at 12:00 as dose 4 (booster), single (Lot number: FP4554) at the age of 57 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient received vaccine. The patient did not receive other medication in 2weeks. Anti-viral details: The patient received treatment with Paxlovid from 28May2022 to 01Jun2022 for treatment of COVID-19. Adverse event: paxlovid recurring symptoms on day 10 from 06Jun2022 at 12:00 AM. The patient was not recovered . No follow-up attempts are possible. No further information is expected.
It is my belief that the 1st dose of the Pfizer vaccine caused inflammation in the discs in my neck and back which aggravated the already existing bulging discs. This has affected my arms, hands, legs and feet with tingling and numbness.  (MRIs have confirmed the bulging discs.)  My orthopedic Dr.  is unable to link it to the vaccine since he has not heard of anything like that as a symptom.  The very day i received the Pfizer-BioNTech Covid-19 vaccine is when I went home and sat at my computer and my legs and feet fell asleep. Raising my legs only helped them to feel half asleep, and they continue to feel half asleep to this day.   Progression of Symptoms within one (1) hour of receiving the shot as I waited in the waiting room: Pain and headache in my left eye, (20 min after receiving vaccine), which lasted 5-10 minutes. Numbness through my arms (35 min after receiving vaccine), Numbness and paralyzing headache in my forehead and felt flushed, (35 min after receiving vaccine), which lasted 15 minutes, Numbness and tingling went down my whole body. Progression of Symptoms within the next 2-3 hours of receiving the shot:  Felt tired and drained of energy. Numbness and tingling in legs and feet (which continues to this day), Extremely Achy Legs, Progression of Symptoms within that night:  Body aches and chills. Further issues - my arm started to fall asleep and I did not connect it to the vaccine at the time but wondered why it had started to give me problems along with my neck. AFTER VARIOUS TESTS, THE PROBLEM SEEMS TO BE BULGING DISCS IN MY NECK AND BACK. Surgery is recommended to possibly alleviate the pain.
fever started 5 hours after vaccine.  She then had facial tingling and muscle twitch.
1-23-12 received 3rd GARDASIL in (R) deltoid. Around 5pm (same day) started with a slight twitch to (R) arm and then started jerking and she felt dizzy. Was seen at ER given 125mg steroid Methylprednisolone and 50mg IV Diphenhydramine and it stopped but started again early next day.
This spontaneous report was received from a register nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 06-JAN-2017, the patient was vaccinated with ZOSTAVAX vial, subcutaneously (lot# L021612 and expiration date: 10-SEP-2016). The vaccination was expired. No adverse effects was reported. Additional information has been requested.
Cutaneous lesions started appearing on my arm and leg and now my back and trunk and groin.
Dizziness, Headache, Myalgia, arm pain, redness at injection site Narrative:   Other Relevant History:
Injection site (thigh) blew up, at least doubled in size and became beet red, high pitch inconsolable hysterical crying for hours (encephalitis). Brought her back to the dr., who admitted this was an unusual adverse reaction but didn't inform me about VAERS (as a first time mom I didn't know my rights). Instructed me to give infant TYLENOL.
Post vaccination patient complained of chest heaviness, vitals were taken BP 97/66, Pulse 73, O2 97% on RA, RR 20/min, patient was monitored for an additional 15 mins and vitals were retaken BP 113/75, pulse 66, O2 99% on RA and RR 16/min. Patient then verbalized complaining of numbness on right side of hemiface and was taken to the Emergency Department for further evaluation.
Swollen, red, itchy, upper arm (approximately 5 inches diameter) down to elbow.
Patient reported pain in arms and neck that also traveled to her legs. She reports swelling in both legs.
SWELLING ON BOTH LEGS THAT STARTED ON THE LEFT SIDE FROM THE KNEE TOWARDS THE UPPER THIGH; TIGHTNESS OF LEGS; WEAKNESS IN LEGS THAT STARTED ON THE LEFT SIDE FROM THE KNEE TOWARDS THE UPPER THIGH; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high-blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced swelling on both legs that started on the left side from the knee towards the upper thigh. On APR-2021, the subject experienced tightness of legs. On APR-2021, the subject experienced weakness in legs that started on the left side from the knee towards the upper thigh. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swelling on both legs that started on the left side from the knee towards the upper thigh, weakness in legs that started on the left side from the knee towards the upper thigh, and tightness of legs. This report was non-serious.
Patient received dose 1 Moderna COVID Vaccine, and was administered dose 1 Pfizer vaccine.  Dose 1 was verbally reported by the patient multiple times to be Pfizer product.  Error identified after Pfizer vaccine was administered.  When the error was identified, the COVID procedure manual was consulted for follow-up recommendations.  Patient was informed. Supervisor was informed.
shingles; Information was received from a lawyer regarding a case in litigation concerning a 60-year-old female patient (pt). The pt's medical history, concurrent conditions, or concomitant medication were not provided. On an unspecified day in 12-JUL-2016, the pt was inoculated at a pharmacy with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date not provided) for prophylaxis. As a result of her receipt of zoster vaccine live (ZOSTAVAX), on an unspecified day in 2016, the pt suffered serious and dangerous side effects including shingles (herpes zoster) including any and all its sequelae as well as other severe and personal injuries which were permanent and lasting in nature. As a result of her receipt of zoster vaccine live (ZOSTAVAX), the pt suffered severe personal injuries, pain, suffering, and emotional distress, as well as to incurred substantial economic damages. In addition, the pt required and would continue to require healthcare and services. The pt incurred and would continue to incur medical and related expenses. The pt also suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other losses and damages. The pt 's direct medical losses and costs include physician care, monitoring, and treatment. Patient has incurred and will continue to incur mental and physical pain and suffering. Outcome of herpes zoster was reported as not resolved. The causal relationship between the event was reported as related to zoster vaccine live (ZOSTAVAX).  The reporter herpes zoster to be a disabling event.
Patient brought to the ED due to increased confusion.  Patient admitted to hospital for Covid pneumonia, hypokalemia, and acute UTI.
Pt recvd 1 dose of Engerix-B & exp pain @ inject site & twitching of the muscle of that arm;
Patient reports left arm was bright red, warm to the touch in the deltoid area with hives, arm ached with headache.  He applied ice and began taking Benadryl on 10/9 50mg every 6 hours, which he reports lessened the hives.
Numbness in leg progressed to arm, neck then to face. Back X-rays and EMG of leg both were normal. Lasted 6 months.
Severe headache pain in the eyes a lot of pain in the body breast pain the arm swollen and red nausea
symptoms: Heart Palpitations, anxiety attacks, shortness of breath, severe loss of appetite, weight loss (22 pounds) increased depression, elevated cortisol levels and increased tinnitus and vertigo.  cortisol levels confirmed after 4 doctor appointments and appointment with cardiologist confirmed tachycardia.  started supplement phosphatidylserine 2/17/21 symptoms improved but cortisol levels remain elevated. I am continuing  treatment with an endocrinologist  at this time.
Immediate extremely strong metallic taste in mouth.  Tongue and lips a little puffy. Very inflamed lymph nodes in neck.  Metallic taste went to gums, and I could feel the metal taste scallop across my teeth, from left to right.  Felt a sweaty sensation on top of head, like I had a bowl on top of my head.  Metallic taste started going down my throat.  Soft palate swollen causing gagging due to uvula touching my tongue.  Could feel the sensation on my head inching its way down my head.  It stopped at the hairline  above my ears, which made me think that I was getting in feeling in my hair follicles and not a sweaty sensation.  Stayed 70 minutes at site.  Metallic taste mostly gone.  I was told to pick up some Benedryl.  As soon as I took it I felt a strong pounding in my ears.  When eating dinner I could feel a slight constriction while swallowing.  The next morning  the lymph nodes in my armpits were extremely sore.  Neck lymph nodes stopped being sore Saturday, but are still a little swollen.  Lymph nodes in arm pits were better on Sunday, but are still sore if pushed on.
Pt recvd vax & devel joint swelling which the pt felt was very similar to rheumatism; pt was seen by MD; No further details were provided;
Four months after I got my second shot, I was diagnosed with Shingles on my R forehead extending over the R eye and R temple
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 13-NOV-2014, the patient was vaccinated with an expired dose of ROTATEQ (lot # H012974, expiry date 07-FEB-2014, dose 2 mil, oral). Concomitant medications were not reported. No adverse effect was reported. The outcome of receiving an expired dose of vaccine was unknown. No product quality complaint was involved. Additional information has been requested.
INJECT RECVD EITHER 5-15 OR 5-17, 1990. PT EXP DIARRHEA, FEVER, HEADACHE, FLU LIKE SYMPTOMS.
Iodiopathic Transverse myelitis; This is a literature report for the following literature source(s): This is a literature report based on a Health Authority database analysis.  A 71-year-old female patient received BNT162b2 (BNT162B2), on 03May2021 as dose 2, single (Batch/Lot number: unknown) at the age of 71 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for COVID-19 immunisation. The following information was reported: MYELITIS TRANSVERSE (medically significant) with onset 03May2021, outcome "unknown", described as "Iodiopathic Transverse myelitis".  Adverse event summary reported as headache fatigue and cramping evening of the second vaccination. Following evening: chills, fatigue, pain and heaviness in lower extremities legs, progressing to inability to walk. Treatment symptomatic. Dianosed as iodiopathic transverse myelitis. The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging spinal: normal.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information and temporal relationship, a possible causal relationship cannot be excluded between the suspect vaccine bnt162b2 and the event Myelitis transverse. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202300065338 Same article/ drug/event and different patient;
1 day post shot...swelling in the region where shot was received; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Apr2021 at 14:15 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included depression, irritable bowel syndrome and fibro. The patient's known allergies were not reported. Concomitant medications included quetiapine fumarate (SEROQUEL) and EFFECTOR; both from an unknown date for unspecified indications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 08:00, the patient experienced "1 day post shot... swelling in the region where shot was received". Therapeutic measures were taken as a result of the event and included treatment with Tylenol. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event "1 day post shot swelling in the region where shot was received" was recovering at the time of reporting.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Cheek swelling on left side of face. With numbing of lip due to swelling; Cheek swelling on left side of face. With numbing of lip due to swelling; Cheek swelling on left side of face. With numbing of lip due to swelling; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: El3302), via an unspecified route of administration in left arm on 13Jan2021 10:00 as single dose and received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: En5318) via an unspecified route of administration in left arm on 04Feb2021 11:00 as single dose for COVID-19 immunization. Patient age was 43-years-old and was not pregnant at the time of vaccination. Vaccine was administered at the military facility. Patient medical history included sleep apnoea syndrome. The patients concomitant medication included melatonin taken for an unspecified indication, start and stop date were not reported. The patient experienced cheek swelling on left side of face with numbing of lip due to swelling with numbing of lip due to swelling on 25Jan2021. No other vaccine in four weeks. Emergency room/department or urgent care. No COVID prior vaccination. No covid tested post vaccination. Therapeutic measures were taken as a result of the event. The outcome of the events was recovering.
Observed resident with left side weakness and facial drop. neurological sign checked and left side found flaccid and unable to move. 911 called.  Notified of pt sent via 911 to hospital
Patient says she received Shingrix vaccine on Monday, 8/15/22 and on Wednesday 8/17/22 she noticed a blister like rash on her pinky toe.   Patient thinks the Shingrix vaccine gave her shingles. She went to urgent care on Thursday 8/18/22 morning.  They diagnosed it as shingles and prescribed her an antiviral medication.  She said urgent care provider advised her never to get the second dose of Shingrix.
Had symptoms after shot of: electrical shooting pain down legs, chills, dizziness, fatigue, profuse sweating.
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PROPRANOLOL and HYDROXYZINE for Anxiety, VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for Depression.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other Concomitant products included unknown drug for birth control.   This case was linked to MOD-2021-378037, MOD-2021-377816 (Patient Link).
Seizure; I had bitten my tongue; This is a spontaneous report from a contactable consumer (patient). A 20-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EW0191) via an unspecified route of administration, administered on the left arm on 27May2021 14:45 as 2nd dose, single for COVID-19 immunisation. Medical history included Type 1 diabetes, epilepsy and PCOS. Concomitant medications included insulin aspart (NOVOLOG); insulin glargine (LANTUS); levetiracetam (KEPPRA); drospirenone, ethinylestradiol (OCELLA) and cran-stat. The patient previously received first dose of BNT162B2 on 06May2021 for COVID-19 immunization (lot number: EW0173, on 06May2021 01:30 PM, left arm). On 28May2021 11:30 AM, the day after 2nd shot the patient woke up on the kitchen floor. She believed she had a seizure because she couldn't remember falling and she had bitten her tongue. No treatment was received for the events. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the events was recovered on an unspecified date.
Patient came to pharmacy with father to receive the first Covid vaccine from Pfizer. Father reported that the patient's DOB at the time of service and the patient was given the vaccine as directed follow the CDC guidance.  Upon billing the patient, a search was conducted to find the patient most current insurance in which her insurance rejected the claim reporting the patient's registered DOB as on their records.  When following up with the patient's father to reconfirm the date of birth, the parents were not able to be reached and have not made a return call.